These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

834 related items for PubMed ID: 19421932

  • 1. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 2. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.
    Rev Cardiovasc Med; 2008 May; 9(4):239-58. PubMed ID: 19122582
    [Abstract] [Full Text] [Related]

  • 3. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of dyslipidemia in clinical practice].
    Paragh G, Harangi M.
    Orv Hetil; 2006 Mar 05; 147(9):389-94. PubMed ID: 16619956
    [Abstract] [Full Text] [Related]

  • 5. What is the most effective strategy for managing diabetic dyslipidaemia?
    Reasner CA.
    Atheroscler Suppl; 2005 Sep 05; 6(3):21-7. PubMed ID: 16054442
    [Abstract] [Full Text] [Related]

  • 6. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb 05; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 7. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ, Lundman P, Tardif JC.
    Eur J Cardiovasc Prev Rehabil; 2010 May 05; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [Abstract] [Full Text] [Related]

  • 8. Management of dyslipidemia in diabetes.
    Solano MP, Goldberg RB.
    Cardiol Rev; 2006 May 05; 14(3):125-35. PubMed ID: 16628021
    [Abstract] [Full Text] [Related]

  • 9. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 10. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A.
    Diabetes Metab Res Rev; 2008 Apr 21; 24(4):286-93. PubMed ID: 18273835
    [Abstract] [Full Text] [Related]

  • 11. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M.
    ChemMedChem; 2008 Feb 21; 3(2):206-21. PubMed ID: 17963209
    [Abstract] [Full Text] [Related]

  • 12. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A.
    Exp Clin Endocrinol Diabetes; 2003 Aug 21; 111(5):239-45. PubMed ID: 12951627
    [Abstract] [Full Text] [Related]

  • 13. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 21; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 14. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 21; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 15. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L, Dani G.
    Orv Hetil; 2016 May 08; 157(19):746-52. PubMed ID: 27133274
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ.
    Metab Syndr Relat Disord; 2009 Apr 08; 7(2):83-8. PubMed ID: 19400742
    [Abstract] [Full Text] [Related]

  • 17. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
    Backes JM, Gibson CA.
    Ann Pharmacother; 2005 Mar 08; 39(3):523-6. PubMed ID: 15671087
    [Abstract] [Full Text] [Related]

  • 18. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
    Wierzbicki AS.
    Diabetes Obes Metab; 2009 Mar 08; 11(3):261-70. PubMed ID: 17645560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 08; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.